Bioinks from All‐Natural Pickering Emulgels Co‐Stabilized by Cationic CNC and Inclusion Complexes Formed by α‐Cyclodextrin
Source abstract
Abstract
Abstract Direct ink writing is especially relevant to the biomedical field due to the customizable extrusion and the possibility of creating pre‐designed architectures. Abundant natural polymers are sustainable and biocompatible alternatives to synthetic and persistent polymers. The printing of pure nanocellulose suspensions proves difficult due to low solid loadings, high shrinkage, as well as non‐fitting rheology. Emulsion gels (emulgel) alternatives gain attention in the field owing to their favorable viscoelastic properties and the possibility of creating multiphase systems. The authors’ sulfur‐free cationic cellulose nanocrystals (CNC) of low degree of substitution enable straightforward deployment in Pickering emulsions. An emulgel ink co‐stabilized by cationic CNC and α‐cyclodextrin is introduced as an interfacial inclusion complex. All ink components are natural and biodegradable compounds. The produced emulgel inks allow for high fidelity printing and minimum shrinkage upon drying that relaxes the need for supports, even in complex overhanging structures. A low yield stress (230–270 Pa) facilitates the inclusion of cells for biomedical applications into the formulation. The emulgel can be tuned to the desired rheological properties and be equipped with both polar and apolar compounds due to the biphasic system, making it a promising platform for biocompatible additive manufacturing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: biodegradable polymer synthesis and properties · Polymer composites and self-healing · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Colloid Chemistry Max Planck Institute of Colloids and Interfaces Am Mühlenberg 1 14472 Potsdam Germany
Bioproducts Institute Department of Chemical and Biological Engineering Department of Chemistry and Department of Wood Science University of British Columbia 2360 East Mall Vancouver British Columbia V6T 1Z4 Canada
Department of Chemical Engineering Queen's University 19 Division Street Kingston Ontario K7L 2N9 Canada
Funding
Max-Planck-Gesellschaft
References (47)
Show source-provided references
1. 10.1088/1758-5090/8/3/03200210.1088/1758-5090/8/3/032002 ↗
2. 10.3390/bioengineering603006510.3390/bioengineering6030065 ↗
3. 10.1039/D1MA00525A10.1039/D1MA00525A ↗
4. 10.1016/j.biomaterials.2005.07.03110.1016/j.biomaterials.2005.07.031 ↗
5. 10.1016/j.engreg.2020.12.00110.1016/j.engreg.2020.12.001 ↗
6. 10.1016/B978-0-08-101103-4.00008-910.1016/B978-0-08-101103-4.00008-9 ↗
7. 10.3390/bioengineering802002710.3390/bioengineering8020027 ↗
8. 10.1016/B978-0-12-800972-7.00013-X10.1016/B978-0-12-800972-7.00013-X ↗
9. Kroschwitz J. I. · 1996
10. 10.1016/j.carbpol.2018.09.02710.1016/j.carbpol.2018.09.027 ↗
11. 10.1021/acssuschemeng.7b0343910.1021/acssuschemeng.7b03439 ↗
12. 10.1021/acspolymersau.1c0004510.1021/acspolymersau.1c00045 ↗
13. 10.1016/j.carbpol.2021.11811410.1016/j.carbpol.2021.118114 ↗
14. 10.1002/adfm.20160461910.1002/adfm.201604619 ↗
15. 10.1021/acsnano.8b0236610.1021/acsnano.8b02366 ↗
16. 10.1002/anbr.20200009710.1002/anbr.202000097 ↗
17. 10.1039/C6SM02682F10.1039/C6SM02682F ↗
18. 10.1021/acs.biomac.2c0091610.1021/acs.biomac.2c00916 ↗
19. 10.1016/j.jcis.2023.06.20910.1016/j.jcis.2023.06.209 ↗
20. 10.1021/acsbiomaterials.9b0052210.1021/acsbiomaterials.9b00522 ↗
21. 10.1039/C8GC00134K10.1039/C8GC00134K ↗
22. 10.1021/acs.biomac.7b0156410.1021/acs.biomac.7b01564 ↗
23. 10.1039/D1MH01741A10.1039/D1MH01741A ↗
24. 10.1016/j.cis.2013.08.00110.1016/j.cis.2013.08.001 ↗
25. 10.1098/rsta.2015.013910.1098/rsta.2015.0139 ↗
26. 10.1016/j.jcis.2020.04.00110.1016/j.jcis.2020.04.001 ↗
27. 10.1007/s11947-020-02481-210.1007/s11947-020-02481-2 ↗
28. 10.1016/j.carbpol.2020.11748310.1016/j.carbpol.2020.117483 ↗
29. 10.1016/j.jaip.2020.09.02910.1016/j.jaip.2020.09.029 ↗
30. 10.1186/s13223-016-0172-710.1186/s13223-016-0172-7 ↗
31. 10.1021/acsnano.1c0592210.1021/acsnano.1c05922 ↗
32. 10.1038/s41577-022-00825-x10.1038/s41577-022-00825-x ↗
33. 10.1021/la025713510.1021/la0257135 ↗
34. 10.1039/C2SM26472B10.1039/C2SM26472B ↗
35. 10.1039/c3cp52116h10.1039/c3cp52116h ↗
36. 10.1016/S0378-5173(03)00384-310.1016/S0378-5173(03)00384-3 ↗
37. 10.1007/BF0105363710.1007/BF01053637 ↗
38. 10.1016/j.ijpharm.2009.11.03510.1016/j.ijpharm.2009.11.035 ↗
39. 10.1080/0098644900894057110.1080/00986449008940571 ↗
40. 10.1021/acs.langmuir.8b0286110.1021/acs.langmuir.8b02861 ↗
41. 10.1038/s41598-021-85865-410.1038/s41598-021-85865-4 ↗
42. 10.1038/s41598-019-40469-x10.1038/s41598-019-40469-x ↗
43. 10.1021/acs.biomac.9b0052710.1021/acs.biomac.9b00527 ↗
44. 10.1021/acsami.7b0275610.1021/acsami.7b02756 ↗
45. 10.1021/acsami.9b2343010.1021/acsami.9b23430 ↗
46. 10.1016/j.addma.2023.10367710.1016/j.addma.2023.103677 ↗
47. 10.1039/D0GC04282J10.1039/D0GC04282J ↗